Published in Contact Dermatitis on November 01, 2005
Ethylene oxide allergy may have been confirmed by patch testing to a similar epoxy compound. Contact Dermatitis (2006) 0.75
An outbreak of irritant contact dermatitis from ethylene oxide among pharmaceutical workers. Contact Dermatitis (1995) 1.92
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med (2012) 5.44
Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med (2008) 4.54
T-helper-1-cell cytokines drive cancer into senescence. Nature (2013) 4.47
Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol (2008) 3.71
Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practice. J Dtsch Dermatol Ges (2011) 2.82
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol (2011) 2.29
Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity (2003) 2.03
TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell (2008) 1.91
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med (2002) 1.86
Proteins of nucleotide and base excision repair pathways interact in mitochondria to protect from loss of subcutaneous fat, a hallmark of aging. J Exp Med (2010) 1.86
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J Exp Med (2011) 1.81
Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest (2007) 1.67
Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. Arch Dermatol (2011) 1.62
Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol (2009) 1.49
Effective T-cell recall responses require the taurine transporter Taut. Eur J Immunol (2012) 1.42
DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood (2005) 1.39
Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol (2007) 1.33
Dermoscopy of tungiasis. Arch Dermatol (2004) 1.29
Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis. Cancer Res (2010) 1.23
Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin. Immunity (2007) 1.21
Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. Cell Res (2005) 1.21
ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat Med (2011) 1.21
Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use. J Cataract Refract Surg (2008) 1.20
Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells. Sci Signal (2013) 1.19
Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J (2010) 1.19
HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood (2007) 1.19
No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol (2004) 1.16
Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PLoS One (2010) 1.14
Explanation of photon correlations in the far-off-resonance optical emission from a quantum-dot-cavity system. Phys Rev Lett (2009) 1.13
CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J Immunol (2005) 1.12
Blunted IgE-mediated activation of mast cells in mice lacking the Ca2+-activated K+ channel KCa3.1. J Immunol (2008) 1.09
EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion. Blood (2009) 1.06
Topical timolol for small hemangiomas of infancy. Pediatr Dermatol (2012) 1.06
Treatment of psoriasis with fumaric acid esters (Fumaderm). J Dtsch Dermatol Ges (2007) 1.05
Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities. J Allergy Clin Immunol (2004) 1.04
Imaging of delayed-type hypersensitivity reaction by PET and 18F-galacto-RGD. J Nucl Med (2005) 1.03
The impact of erythrocyte age on eryptosis. Br J Haematol (2012) 1.00
Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation. Blood (2009) 0.98
Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum (2007) 0.97
The NFĸB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes. Cell Physiol Biochem (2011) 0.96
Eosinophilic fasciitis and combined UVA1--retinoid--corticosteroid treatment: two case reports. Acta Derm Venereol (2008) 0.95
Staphylococcus aureus skin colonization is promoted by barrier disruption and leads to local inflammation. Exp Dermatol (2013) 0.95
Calcineurin inhibitors and rapamycin: cancer protection or promotion? Exp Dermatol (2007) 0.95
A young woman with recurrent vesicles on the lower lip: fixed drug eruption mimicking herpes simplex. Acta Derm Venereol (2008) 0.94
TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J Investig Dermatol Symp Proc (2004) 0.94
Psychological burden of food allergy. World J Gastroenterol (2007) 0.93
T cell-mediated help against tumors. Cell Cycle (2008) 0.93
The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute. Invest Ophthalmol Vis Sci (2012) 0.93
Mast cells: novel clinical perspectives from recent insights. Exp Dermatol (2009) 0.92
'To repair or not to repair - no longer a question': repair of mitochondrial DNA shielding against age and cancer. Exp Dermatol (2006) 0.92
IL-4-mediated fine tuning of IL-12p70 production by human DC. Eur J Immunol (2008) 0.92
Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma. Clin Cancer Res (2008) 0.91
In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue. J Nucl Med (2014) 0.90
Innate immune sensing 2.0 - from linear activation pathways to fine tuned and regulated innate immune networks. Exp Dermatol (2012) 0.90
Para-phenylenediamine-specific lymphocyte activation test: a sensitive in vitro assay to detect para-phenylenediamine sensitization in patients with severe allergic reactions. Exp Dermatol (2010) 0.89
A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses. J Mol Med (Berl) (2003) 0.89
Impaired mast cell activation in gene-targeted mice lacking the serum- and glucocorticoid-inducible kinase SGK1. J Immunol (2009) 0.89
Radiation recall dermatitis and radiation pneumonitis during treatment with vemurafenib. Melanoma Res (2014) 0.89
Wavelet analysis of skin perfusion in healthy volunteers. Microcirculation (2007) 0.87
Pagetoid reticulosis (Woringer-Kolopp disease). J Dtsch Dermatol Ges (2008) 0.87
Sulforaphane protects from T cell-mediated autoimmune disease by inhibition of IL-23 and IL-12 in dendritic cells. J Immunol (2014) 0.87
Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells. Invest Ophthalmol Vis Sci (2008) 0.86
Age sensitivity of NFκB abundance and programmed cell death in erythrocytes induced by NFκB inhibitors. Cell Physiol Biochem (2013) 0.86
Angiogenesis: the new potential target for the therapy of psoriasis? Drug News Perspect (2008) 0.86
[Atopic dermatitis: S2 guidelines]. J Dtsch Dermatol Ges (2009) 0.86
Requirements for control of B-cell lymphoma by NK cells. Eur J Immunol (2010) 0.86
Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling. Am J Physiol Cell Physiol (2010) 0.86
Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th subset differentiation. Eur J Dermatol (2002) 0.85
Treatment of disseminated granuloma annulare with low-dose fumaric acid. Acta Derm Venereol (2009) 0.85
Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo. PLoS Pathog (2010) 0.85
CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells. J Invest Dermatol (2011) 0.84
Subunits of IgM reconstitute defective contact sensitivity in B-1 cell-deficient xid mice: kappa light chains recruit T cells independent of complement. J Immunol (2002) 0.84
Fixed food eruption caused by asparagus. J Allergy Clin Immunol (2005) 0.84
Tetraspanins in mast cells. Front Immunol (2012) 0.84
CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis. J Invest Dermatol (2011) 0.83
Design, synthesis, and biological evaluation of novel 3-aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as vascular endothelial growth factor receptor (VEGF-R) inhibitors. J Med Chem (2008) 0.83
Tinea incognito hidden under apparently treatment-resistant pemphigus foliaceus. Acta Derm Venereol (2008) 0.83
Glycosylation of Candida albicans cell wall proteins is critical for induction of innate immune responses and apoptosis of epithelial cells. PLoS One (2012) 0.83
PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease. Eur J Dermatol (2008) 0.82
Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease. Cell Transplant (2014) 0.82
Th2 cells shape the differentiation of developing T cell responses during interactions with dendritic cells in vivo. Eur J Immunol (2003) 0.82
Non-invasive monitoring of pancreatic tumor progression in the RIP1-Tag2 mouse by magnetic resonance imaging. Mol Imaging Biol (2013) 0.82
Treatment of severe acne with low-dose isotretinoin. Acta Derm Venereol (2012) 0.82
Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA). Radiat Oncol (2011) 0.82
Variability of dermoscopic features of tungiasis. Arch Dermatol (2005) 0.81
In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival. Pigment Cell Melanoma Res (2014) 0.81